Anxiety Disorders
Noradrenergic enhancement of amygdala responses to fear
62
Onur O, Walter H, Schlaepfer T, Rehme A, Schmidt C,
Keysers C, et al (2009). Noradrenergic
enhancement of amygdala responses to fear. Social
Cognitive and Affective Neuroscience (SCAN)
4: 119-126.
View/Download PDF...
View/Download PDF...
Modelling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions
58
Kukolja J, Schlaepfer T, Keysers C, Klingmüller D,
Maier W, Fink G, et al (2008). Modelling a
negative response bias in the human amygdala by
noradrenergic-glucocorticoid interactions. The
Journal of Neuroscience 28(48):
12868-12876.
View/Download PDF...
View/Download PDF...
Diminished GABAA Receptor Binding Capacity and a DNA Base Substitution in a Patient With Treatment Resistant Depression and Anxiety
04
Kosel M, Rudolph U,
Wielepp JP, Luginbuehl M, Schmitt W, Fisch HU,
Schlaepfer TE: Diminished GABAA Receptor Binding
Capacity and a DNA Base Substitution in a Patient
With Treatment Resistant Depression and
Anxiety. Neuropsychopharmacology
29(2):347-350, 2004
PDF A46
PDF A46
Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders
01
Hoehn-Saric
R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson
GD, Wong SH: Cerebral blood flow in
obsessive-compulsive patients with major depression:
effect of treatment with sertraline or desipramine on
treatment responders and non-responders.
Psychiatry Research-Neuroimaging
108:89-100,
2001
PDF A33
PDF A33
Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow-up
98
Eaton
WW, Anthony JC, Romanoski A, Tien A, Gallo J, Cai G,
Neufeld K, Schlaepfer TE, Laugharne J, Chen LS: Onset
and recovery from panic disorder in the Baltimore
Epidemiologic Catchment Area follow-up.
British Journal of Psychiatry
173(12):501-507, 1998
PDF A27
PDF A27